Longitudinal Survey Analysis in Lymphoma Survivors

Completed

• Conditions: Lymphoma; Posttraumatic Stress Disorder; Posttraumatic Growth; Coping; Resilience

• Registration Number: NCT01469754
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD.

Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a "greater appreciation for life", a "stronger relationship with their family/friends," or a "new found level of spirituality" are examples of instances of posttraumatic growth.

Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2011-09
• Study First Submitted: 2011-11-08
• Study First Submitted QC: 2011-11-08
• Study First Posted: 2011-11-10
• Primary Completion: 2013-07
• Study Completion: 2013-09
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-01
• Last Update Posted: 2014-05-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

• Diagnosis of Lymphoma (includes Waldenstrom's Macroglobulinemia)
• Can read/write/understand English without a translator

Read More

Exclusion Criteria

• Currently Hospitalized
• Active Psychosis

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Posttraumatic Growth	Measured at enrollment

Secondary Outcome Measures

Name	Time	Method
Posttraumatic Stress Disorder (PTSD)	Measured at Enrollment

Trial Locations

Locations (1)

New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma; 🇺🇸 New York, New York, United States